178 related articles for article (PubMed ID: 22716211)
1. Gene expressional changes in prostate fibroblasts from cancerous tissue.
Reinertsen T; Halgunset J; Viset T; Flatberg A; Haugsmoen LL; Skogseth H
APMIS; 2012 Jul; 120(7):558-71. PubMed ID: 22716211
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast and prostate tumor cell cross-talk: fibroblast differentiation, TGF-β, and extracellular matrix down-regulation.
Coulson-Thomas VJ; Gesteira TF; Coulson-Thomas YM; Vicente CM; Tersariol IL; Nader HB; Toma L
Exp Cell Res; 2010 Nov; 316(19):3207-26. PubMed ID: 20727350
[TBL] [Abstract][Full Text] [Related]
3. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
4. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast transdifferentiation.
Untergasser G; Gander R; Lilg C; Lepperdinger G; Plas E; Berger P
Mech Ageing Dev; 2005 Jan; 126(1):59-69. PubMed ID: 15610763
[TBL] [Abstract][Full Text] [Related]
5. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
6. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
7. The type III transforming growth factor-beta receptor as a novel tumor suppressor gene in prostate cancer.
Turley RS; Finger EC; Hempel N; How T; Fields TA; Blobe GC
Cancer Res; 2007 Feb; 67(3):1090-8. PubMed ID: 17283142
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
9. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
10. TGFBR3 loss and consequences in prostate cancer.
Sharifi N; Hurt EM; Kawasaki BT; Farrar WL
Prostate; 2007 Feb; 67(3):301-11. PubMed ID: 17192875
[TBL] [Abstract][Full Text] [Related]
11. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model.
McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR
Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910
[TBL] [Abstract][Full Text] [Related]
12. Differential metastasis-associated gene analysis of prostate carcinoma cells derived from primary tumor and spontaneous lymphatic metastasis in nude mice with orthotopic implantation of PC-3M cells.
Chu JH; Sun ZY; Meng XL; Wu JH; He GL; Liu GM; Jiang XR
Cancer Lett; 2006 Feb; 233(1):79-88. PubMed ID: 15885894
[TBL] [Abstract][Full Text] [Related]
13. A novel function of differentiation revealed by cDNA microarray profiling of p75NTR-regulated gene expression.
Nalbandian A; Pang AL; Rennert OM; Chan WY; Ravindranath N; Djakiew D
Differentiation; 2005 Oct; 73(8):385-96. PubMed ID: 16316409
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts.
Sato N; Maehara N; Goggins M
Cancer Res; 2004 Oct; 64(19):6950-6. PubMed ID: 15466186
[TBL] [Abstract][Full Text] [Related]
15. A bioengineered microenvironment to quantitatively measure the tumorigenic properties of cancer-associated fibroblasts in human prostate cancer.
Clark AK; Taubenberger AV; Taylor RA; Niranjan B; Chea ZY; Zotenko E; Sieh S; Pedersen JS; Norden S; Frydenberg M; Grummet JP; Pook DW; ; Stirzaker C; Clark SJ; Lawrence MG; Ellem SJ; Hutmacher DW; Risbridger GP
Biomaterials; 2013 Jul; 34(20):4777-85. PubMed ID: 23562048
[TBL] [Abstract][Full Text] [Related]
16. Interactions between normal human fibroblasts and human prostate cancer cells in a co-culture system.
Iacopino F; Angelucci C; Sica G
Anticancer Res; 2012 May; 32(5):1579-88. PubMed ID: 22593435
[TBL] [Abstract][Full Text] [Related]
17. Heterogenous induction of carcinoma-associated fibroblast-like differentiation in normal human prostatic fibroblasts by co-culturing with prostate cancer cells.
Ishii K; Mizokami A; Tsunoda T; Iguchi K; Kato M; Hori Y; Arima K; Namiki M; Sugimura Y
J Cell Biochem; 2011 Dec; 112(12):3604-11. PubMed ID: 21809373
[TBL] [Abstract][Full Text] [Related]
18. Focal degeneration of basal cells and the resultant auto-immunoreactions: a novel mechanism for prostate tumor progression and invasion.
Man YG; Gardner WA
Med Hypotheses; 2008; 70(2):387-408. PubMed ID: 17658698
[TBL] [Abstract][Full Text] [Related]
19. Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification.
Ding Y; Xu L; Chen S; Jovanovic BD; Helenowski IB; Kelly DL; Catalona WJ; Yang XJ; Pins M; Ananthanarayanan V; Bergan RC
Prostate Cancer Prostatic Dis; 2006; 9(4):379-91. PubMed ID: 16786039
[TBL] [Abstract][Full Text] [Related]
20. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS
Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
